Susan Tom

563 total citations
14 papers, 428 citations indexed

About

Susan Tom is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Susan Tom has authored 14 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Genetics. Recurrent topics in Susan Tom's work include CRISPR and Genetic Engineering (5 papers), Lysosomal Storage Disorders Research (5 papers) and Virus-based gene therapy research (3 papers). Susan Tom is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Lysosomal Storage Disorders Research (5 papers) and Virus-based gene therapy research (3 papers). Susan Tom collaborates with scholars based in United States and India. Susan Tom's co-authors include Alexandra Peister, Donna Bertucci, Daniel J. Weiss, Jay K. Kolls, Guoshun Wang, Jeffrey L. Spees, Darwin J. Prockop, Bruce A. Bunnell, Vincent G. Valentine and Nicholas A. Lanson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Susan Tom

14 papers receiving 422 citations

Peers

Countries citing papers authored by Susan Tom

Since Specialization

Citations

This map shows the geographic impact of Susan Tom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Tom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Tom more than expected).

Fields of papers citing papers by Susan Tom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Tom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Tom. The network helps show where Susan Tom may publish in the future.

Co-authorship network of co-authors of Susan Tom

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Tom. A scholar is included among the top collaborators of Susan Tom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Tom. Susan Tom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Investigation of corrosion and water absorption of biomass natural coir fiber/hBN reinforced epoxy hybrid composites using different optimisation approaches 2025 ·Scientific Reports ·K. Ramraji, (unknown), Susan Tom, R. Nagaraj, Ph. Salin, (unknown), G. Venkatachalam, (unknown)	3
2	ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome 2018 ·Molecular Therapy ·Li Ou, Russell C. DeKelver, Michelle Rohde, Susan Tom, Robert Radeke, Susan S. Martin, Yolanda Santiago, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Kathleen Meyer, Michael C. Holmes, R. Scott McIvor, Thomas Wechsler, Chester B. Whitley	64
3	Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing 2018 ·Molecular Therapy ·Kanut Laoharawee, Russell C. DeKelver, Kelly M. Podetz-Pedersen, Michelle Rohde, Scott Sproul, (unknown), Tam T. T. N. Nguyen, Susan S. Martin, Li Ou, Susan Tom, Robert Radeke, Kathleen Meyer, Michael C. Holmes, Chester B. Whitley, Thomas Wechsler, R. Scott McIvor	91
4	ZFN-mediated in vivo genome editing of hepatocytes results in phenotypic correction in murine MPS I and MPS II models 2018 ·Molecular Genetics and Metabolism ·Thomas Wechsler, Russell C. DeKelver, Kanut Laoharawee, Li Ou, Susan Tom, (unknown), Scott Sproul, Brenda Koniar, (unknown), (unknown), Kathleen Meyer, (unknown), (unknown), Michael C. Holmes	1
5	ZFN-mediated in vivo genome editing results in phenotypic correction in murine MPS I and MPS II models 2017 ·Molecular Genetics and Metabolism ·Russell C. DeKelver, Li Ou, Kanut Laoharawee, Susan Tom, Robert Radeke, Michelle Rohde, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, (unknown), Michael C. Holmes, R. Scott McIvor, Chester B. Whitley, Thomas Wechsler	1
6	ZFN-mediated correction of murine MPS I model by expression of the human IDUA cDNA from the albumin “safe harbor” locus 2016 ·Molecular Genetics and Metabolism ·Li Ou, Russell C. DeKelver, Susan Tom, Robert Radeke, (unknown), Amy Manning-Bog, Scott Sproul, (unknown), Brenda Koniar, Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Michael C. Holmes, Thomas Wechsler, R. Scott McIvor, Chester B. Whitley	1
7	485. ZFN-Mediated Liver-Targeting Gene Therapy Corrects Systemic and Neurological Disease of Mucopolysaccharidosis Type I 2016 ·Molecular Therapy ·Li Ou, Russell C. DeKelver, Susan Tom, Robert Radeke, Michelle Rohde, Amy Manning-Bog, Scott Sproul, (unknown), (unknown), Kelly M. Podetz-Pedersen, Kanut Laoharawee, (unknown), Michael C. Holmes, Thomas Wechsler, R. Scott McIvor, Chester B. Whitley	1
8	484. In Vivo Zinc-Finger Nuclease Mediated Iduronate-2-Sulfatase (IDS) Target Gene Insertion and Correction of Metabolic Disease in a Mouse Model of Mucopolysaccharidosis Type II (MPS II) 2016 ·Molecular Therapy ·Kanut Laoharawee, Russell C. DeKelver, (unknown), Susan Tom, Robert Radeke, Michelle Rohde, Amy Manning-Bog, Scott Sproul, Li Ou, Kathleen Meyer, Michael C. Holmes, Chester B. Whitley, Thomas Wechsler, R. Scott McIvor	1
9	ZFN-mediated genome editing of albumin “safe harbor” in vivo results in supraphysiological levels of human IDS, IDUA and GBA in mice 2015 ·Molecular Genetics and Metabolism ·Russell C. DeKelver, Michelle Rohde, Susan Tom, Yolanda Santiago, Scott Sproul, Philip D. Gregory, Michael C. Holmes, Thomas Wechsler	3
10	479. ZFN-Mediated In Vivo Genome Editing Results in Supraphysiological Levels of Lysosomal Enzymes Deficient in Hunter and Hurler Syndrome and Gaucher Disease 2015 ·Molecular Therapy ·Thomas Wechsler, (unknown), Michelle Rohde, Susan Tom, Scott Sproul, (unknown), Kanut Laoharawee, Kelly M. Podetz-Pedersen, Chester B. Whitley, (unknown), Philip D. Gregory, Michael C. Holmes	2
11	TNT009, a Classical Complement Pathway Specific Inhibitor, Prevents Complement Dependent Hemolysis Induced By Cold Agglutinin Disease Patient Autoantibodies 2013 ·Blood ·Sandip Panicker, (unknown), (unknown), Sami Hussain, Susan Tom, W Strober, Steven R. Sloan, Graham C. Parry, Nancy E. Stagliano	8
12	RNA-binding Protein Muscleblind-like 3 (MBNL3) Disrupts Myocyte Enhancer Factor 2 (Mef2) β-Exon Splicing 2010 ·Journal of Biological Chemistry ·(unknown), Yi Cao, (unknown), Susan Tom, Stephen J. Tapscott, Edith H. Wang	31
13	Multiplex genotyping and gene expression assays for colorectal cancer treatment selection markers 2005 ·Journal of Clinical Oncology ·(unknown), (unknown), Susan Tom, Cindy Christopherson, David Wolfson, (unknown), (unknown), John J. Sninsky	2
14	Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis 2004 ·Proceedings of the National Academy of Sciences ·Guoshun Wang, Bruce A. Bunnell, Richard G. Painter, (unknown), Susan Tom, Nicholas A. Lanson, Jeffrey L. Spees, Donna Bertucci, Alexandra Peister, Daniel J. Weiss, Vincent G. Valentine, Darwin J. Prockop, Jay K. Kolls	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact